Jennison Associates
AMRX icon

Jennison Associates’s Amneal Pharmaceuticals AMRX Stock Holding History

Jennison Associates’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92M Buy
168,863
+43,965
+35% +$602K ﹤0.01% 438
2026
Q1 		$1.55M Buy
124,898
+47,497
+61% +$638K ﹤0.01% 455
2025
Q4 		$975K Buy
+77,401
New +$886K ﹤0.01% 503
2025
Q3 		– Sell
-78,548
Closed -$635K – 566
2025
Q2 		$635K Buy
78,548
+7,122
+10% +$53.7K ﹤0.01% 527
2025
Q1 		$599K Buy
+71,426
New +$596K ﹤0.01% 535

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Jennison Associates's AMRX Position: Q2 2026 in Review

Jennison Associates increased its Amneal Pharmaceuticals (AMRX) stake by 35% in Q2 2026, buying an estimated $602K and bringing the position to 168,863 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #438.

Jennison Associates first reported a position in AMRX in Q1 2025 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Jennison Associates held 168,863 shares of Amneal Pharmaceuticals worth $2.92M as of Q2 2026.
  • Jennison Associates bought 43,965 Amneal Pharmaceuticals shares in Q2 2026, an estimated $602K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Jennison Associates's portfolio in Q2 2026, its #438 holding.
  • Jennison Associates first reported a position in Amneal Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.